These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Controlled expression of cardiac-directed adenylylcyclase type VI provides increased contractile function. Gao MH; Bayat H; Roth DM; Yao Zhou J; Drumm J; Burhan J; Hammond HK Cardiovasc Res; 2002 Nov; 56(2):197-204. PubMed ID: 12393090 [TBL] [Abstract][Full Text] [Related]
5. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling. Tepe NM; Lorenz JN; Yatani A; Dash R; Kranias EG; Dorn GW; Liggett SB Biochemistry; 1999 Dec; 38(50):16706-13. PubMed ID: 10600134 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Gao M; Ping P; Post S; Insel PA; Tang R; Hammond HK Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1038-43. PubMed ID: 9448281 [TBL] [Abstract][Full Text] [Related]
7. Effect of overexpressed adenylyl cyclase VI on beta 1- and beta 2-adrenoceptor responses in adult rat ventricular myocytes. Stark JC; Haydock SF; Foo R; Brown MJ; Harding SE Br J Pharmacol; 2004 Oct; 143(4):465-76. PubMed ID: 15381636 [TBL] [Abstract][Full Text] [Related]
8. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation. Tang T; Lai NC; Roth DM; Drumm J; Guo T; Lee KW; Han PL; Dalton N; Gao MH Basic Res Cardiol; 2006 Mar; 101(2):117-26. PubMed ID: 16283593 [TBL] [Abstract][Full Text] [Related]
9. Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy. Timofeyev V; He Y; Tuteja D; Zhang Q; Roth DM; Hammond HK; Chiamvimonvat N J Mol Cell Cardiol; 2006 Jul; 41(1):170-81. PubMed ID: 16750219 [TBL] [Abstract][Full Text] [Related]
10. Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. Ojamaa K; Klein I; Sabet A; Steinberg SF Metabolism; 2000 Feb; 49(2):275-9. PubMed ID: 10690958 [TBL] [Abstract][Full Text] [Related]
11. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function. Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103 [TBL] [Abstract][Full Text] [Related]
12. Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained β-adrenergic stimulation. Gao MH; Lai NC; Giamouridis D; Kim YC; Guo T; Hammond HK PLoS One; 2017; 12(8):e0181282. PubMed ID: 28767701 [TBL] [Abstract][Full Text] [Related]
13. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Takahashi T; Tang T; Lai NC; Roth DM; Rebolledo B; Saito M; Lew WY; Clopton P; Hammond HK Circulation; 2006 Aug; 114(5):388-96. PubMed ID: 16864723 [TBL] [Abstract][Full Text] [Related]
14. Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. Gao MH; Tang T; Guo T; Sun SQ; Feramisco JR; Hammond HK J Biol Chem; 2004 Sep; 279(37):38797-802. PubMed ID: 15231818 [TBL] [Abstract][Full Text] [Related]
15. The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. Tanaka R; Fulbright BM; Mukherjee R; Burchell SA; Crawford FA; Zile MR; Spinale FG J Mol Cell Cardiol; 1993 Oct; 25(10):1215-33. PubMed ID: 8263955 [TBL] [Abstract][Full Text] [Related]
16. Preserved cardiac function despite marked impairment of cAMP generation. Gao MH; Lai NC; Tang T; Guo T; Tang R; Chun BJ; Wang H; Dalton NN; Suarez J; Dillmann WH; Hammond HK PLoS One; 2013; 8(9):e72151. PubMed ID: 24147149 [TBL] [Abstract][Full Text] [Related]
17. Adenylyl cyclase: a new target for heart failure therapeutics. Feldman AM Circulation; 2002 Apr; 105(16):1876-8. PubMed ID: 11997269 [No Abstract] [Full Text] [Related]
18. Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse. Tepe NM; Liggett SB FEBS Lett; 1999 Sep; 458(2):236-40. PubMed ID: 10481072 [TBL] [Abstract][Full Text] [Related]